Wells Fargo’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8K Sell
4,250
-8,376
-66% -$34.9K ﹤0.01% 5818
2025
Q4
$54.4K Buy
12,626
+8,348
+195% +$31.8K ﹤0.01% 5561
2025
Q3
$18.6K Buy
4,278
+659
+18% +$2.97K ﹤0.01% 5811
2025
Q2
$16.8K Buy
+3,619
New +$14.3K ﹤0.01% 5830

Other funds holding SBC

Wells Fargo's SBC Position: Q1 2026 in Review

Wells Fargo reduced its SBC Medical Group (SBC) stake by 66% in Q1 2026, selling an estimated $34.9K and leaving 4,250 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5818.

Wells Fargo first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $54.4K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Wells Fargo held 4,250 shares of SBC Medical Group worth $17.8K as of Q1 2026.
  • Wells Fargo sold 8,376 SBC Medical Group shares in Q1 2026, an estimated $34.9K.
  • SBC Medical Group made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5818 holding.
  • Wells Fargo first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
  • Wells Fargo's SBC Medical Group position peaked at $54.4K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.